The Big Space Cancer Appeal-
-
About our charity and what we stand for
-
A new ‘Fibro Scanner’ is helping to provide early diagnosis and treatment of liver disease for local patients
Thanks to donations and a charitable grant from Norgine Pharmaceuticals, we have been able to fund the latest ‘Fibroscan’ technology at our hospitals.
A Fibro Scanner is a type of ultrasound that is used to assess liver fibrosis in a non-invasive way. The equipment can help to provide a prompt diagnosis, which is especially important as 90% of liver disease is reversible if detected early. This also enables the hepatology team to organise a treatment plan as soon as possible for patients. The Fibroscan procedure is quick and painless, and can also help in emergency situations by providing accurate readings of liver damage in less than 15 minutes.
Deborah Durrant, a Senior Liver Specialist Nurse, said “A Fibroscan is an important diagnostic tool in the prevention and treatment of liver disease. This state-of-the-art equipment is able to provide a much more detailed picture of the health and stage of liver disease of a patient than a standard ultrasound. It is portable so can be easily moved around wards and helps not just our patients, but referrals from rheumatology, dermatology, cardiology, diabetes, haematology and renal departments.”
“Being able to provide patients with an accurate and prompt diagnosis is so important. Previously patients may have had to undergo a liver biopsy, have an inpatient stay or a longer wait for their results. With the Fibro Scanner the procedure is non-invasive, quick and informative, patients can then be guided to make lifestyle changes to optimise their liver health. This equipment really has made a huge difference to both staff and patients and we would like to say thank you to both the charity supporters and Norgine for making this possible.”
Thank you to everyone who chooses to support and helps us fund the latest state-of-the-art equipment for our hospitals.
Making hospital life better
